InvestorsHub Logo
icon url

lasers

11/22/17 10:24 AM

#42074 RE: Titan V #42072

AMGN being a BP took a chance with ADXS.

Any preclinical trials are especially risky and $ONCS Dr. Pierce and others would need to convince any BP that a Partnership risk is worth it with Humans for a Phase1A.